Advertisement
Journal Home
Search for

Volume 37, Issue 3, Pages 392-397 (February 2001)


View previous. 2 of 21 View next.

Are alcohol intake and smoking associated with mycosis fungoides? A European multicentre case–control study.

M.M Morales Suárez-VarelaabCorresponding Author Informationemail address, J Olsenc, L Kaerlevc, P Guéneld, P Arveuxe, G Wingrenf, L Hardellg, W Ahrenshi, A Stangi, A Llopis-Gonzaleza, F Merlettij, F Guillén-Grimak, P Johansenl

Received 30 May 2000; received in revised form 29 August 2000; accepted 26 October 2000.

Abstract 

The incidence of mycosis fungoides (MF) is low, and the aetiology of the disease is unknown. The aim of this study was to investigate whether wine consumption protects against the disease and whether smoking constitutes a risk factor. This paper is part of the European Rare Cancers Study that tries to determine the risk factors for seven selective rare cancers, including mycosis fungoides, involved in the development of cancer. A multicentre case–control study was conducted in six European countries. Only incident cases with confirmed histology were included in the analysis which include a total of 76 cases of MF and 2899 controls. Wine intake had no protective effect; on the contrary the consumption of more than 24 g of alcohol per day was associated with a high risk of MF (odds ratio (OR)=3.02, 95% confidence interval (CI), 1.34–6.79), after adjusting for centre, country, age, sex and education. There was a dose-dependent increase in the risk of MF with increased smoking habits, albeit the observed trend was not statistically significant. A combined exposure to high tobacco and alcohol use yielded a significantly increased risk factor for MF (P=0.0073). Alcohol intake was associated with MF.

a Unit of Public Health and Environmental Care, Department of Preventive Medicine, University of Valencia, Av. Vicente Andrés Estellés s/n, 46100 Burjassot, Valencia, Spain

b Unit of Clinical Epidemiology, Dr. Peset Hospital, Valencia, Spain

c The Danish Epidemiology Science Centre, University of Aarhus, Denmark

d INSERM Uniteé 88, Hôpital National de Saint-Maurice, France

e Registre des cancers du Doubs, France

f Division of Occupational and Environmental Medicine, Department of Health and Environment, Faculty of Health Sciences, Sweden

g Department of Oncology, Örebro Medical Center, Sweden

h Bremen Institute for Prevention Research and Social Medicine, Division of Biometry and Data Processing, Bremen, Germany

i Institute for Medical Informatics, Biometry and Epidemiology, University Clinics, Essen, Germany

j Dipartimento di Scienze Biomediche e Oncologia Umana, Turin, Italy

k Department of Health Sciences, Public University of Navarre, Pamplona, Spain

l Institute of Pathology, Aalborg Hospital, Reberbansgade, DK-9100 Aalborg, Denmark

Corresponding Author InformationCorresponding author. Tel.: +34-963-864-951; fax: +34-963-864-951

PII: S0959-8049(00)00383-X


View previous. 2 of 21 View next.